Ortho Pharmaceuticals Report issue

For profit Phase 3
Founded: Raritan NJ United States (1931)
Status: Acquired by Johnson and Johnson (1993)

Organization Overview

First Clinical Trial
1999
NCT00002073
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree